The role of free radicals in sepsis development

Frontiers in Bioscience - Elite

Volumn 1 E, Issue 1, 2009, Pages 277-287

  Andrades, Michael Everton ^a   Ritter, Cristiane ^b   Dal Pizzol, Felipe ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Antioxidant; Free radical; Infection; Review; Sepsis

Indexed keywords

EID: 84883269239     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Barriere S. L., S. F. Lowry: An overview of mortality risk prediction in sepsis. Crit Care Med 23, 376-393 (1995)
2. Bone R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A Knaus, R. M. Schein, W. J. Sibbald: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101, 1644-1655 (1992)
3. Macarthur H., T. C. Westfall, D. P. Riley, T. P. Misko, D. Salvemini: Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci U S A 97, 9753-9758 (2000) (Pubitemid 30650848)
4. Salvemini D., S. Cuzzocrea: Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med 33, 1173-1185 (2002) (Pubitemid 35246585)
5. Ritter C., M. E. Andrades, A. Reinke, S. Menna-Barreto, J. C. Moreira, F. Dal-Pizzol: Treatment with Nacetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med 32, 342-349 (2004) (Pubitemid 38234109)
6. Hotchkiss R. S., I. E. Karl: The Pathophysiology and Treatment of Sepsis. N Engl J Med 348, 138-150 (2003) (Pubitemid 36056721)
7. Babior B. M.: Phagocytes and oxidative stress. Am J Med 109, 33-44 (2000) (Pubitemid 30608735)
8. Halliwell B, JMC Gutteridge: Free Radicals in Biology and Medicine. Oxford University Press, New York, NY (2007)
9. Asehnoune K., D. Strassheim, S. Mitra, J. Y. Kim, E. Abraham: Involvement of reactive oxygen species in tolllike receptor 4-dependent activation of NF-êB. J Immunol 172, 2522-2529 (2004) (Pubitemid 38182403)
10. de Souza L. F., C. Ritter, D. Pens Gelain, M. E. Andrades, E. A. Bernard, J. C. Moreira, F. Dal-Pizzol: Mitochondrial superoxide production is related to the control of cytokine release from peritoneal macrophage after antioxidant treatment in septic rats. J Surg Res 141, 252-256 (2007) (Pubitemid 47042050)
11. Haddad J. J., H. L. Harb: L-gamma-Glutamyl-Lcysteinylglycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro-and anti-inflammatory cytokines: a signaling transcriptional scenario for redox (y) immunologic sensor (s)? Mol Immunol 42, 987-1014 (2005)
12. Sprong R. C., A. M. Winkelhuyzen-Janssen, C. J. Aarsman, J. F. van Oirschot, T. van der Bruggen, B. S. van Asbeck: Low-dose N-acetylcysteine protects rats against endotoxin-mediated oxidative stress, but highdose increases mortality. Am J Respir Crit Care Med 157, 1283-1293 (1998)
13. Goode H. F., H. C. Cowley, B. E. Walker, P. D. Howdle, N. R. Webster: Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 23, 646-651 (1995)
14. Cowley H. C., P. J. Bacon, H. F. Goode, N. R. Webster, J. G. Jones, D. K. Menon: Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 24, 1179-1183 (1996) (Pubitemid 26249370)
15. Pascual C., W. Karzai, A. Meier-Hellmann, M. Oberhoffer, A. Horn, D. Bredle, K. Reinhart: Total plasma antioxidant capacity is not always decreased in sepsis. Crit Care Med 26, 705-709 (1998) (Pubitemid 28201417)
16. Alonso de Vega J. M., J. Diaz, E. Serrano, L. F. Carbonell: Plasma redox status relates to severity in critically ill patients. Crit Care Med 28, 1812-1814 (2000) (Pubitemid 30428735)
17. Wichterman K. A., A. E. Baue, I. H. Chaudry: Sepsis and septic shock-A review of laboratory models and a proposal. J. Surg Res 29, 189-201 (1980) (Pubitemid 10039498)
18. Kunimoto F., T. Morita, R. Ogawa and T. Fujita: Inhibition of lipid peroxidation improves survival rate of endotoxemic rats. Circ Shock 21, 15-22 (1987) (Pubitemid 17220163)
19. Ritter C., M. E. Andrades, M. L. Frota Junior, F. Bonatto, R. A. Pinho, M. Polydoro, F. Klamt, C. T. Pinheiro, S. S. Menna-Barreto, J. C. Moreira, F. Dal-Pizzol: Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med 29, 1782-1789 (2003) (Pubitemid 37373825)
20. Jacobi J., B. Kristal, J. Chezar, S. M. Shaul, S. Sela: Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures. Free Radic Biol Med 39, 1238-1248 (2005) (Pubitemid 41407716)
21. O'Donnell V. B., J. P. Eiserich, P. H. Chumley, M. J. Jablonsky, N. R. Krishna, M. Kirk, S. Barnes, V. M. Darley-Usmar, B. A. Freeman: Nitration of unsaturated fatty acids by nitric oxide-derived reactive nitrogen species peroxynitrite, nitrous acid, nitrogen dioxide, and nitronium ion. Chem Res Toxicol 12, 83-92 (1999) (Pubitemid 29048836)
22. Szabo C., S. Cuzzocrea, B. Zingarelli, M. O'Connor, A. L. Salzman: Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 100, 723-735 (1997) (Pubitemid 27340522)
23. Kirkland J. B.: Lipid peroxidation, protein thiol oxidation and DNA damage in hydrogen peroxideinduced injury to endothelial cells: role of activation of poly (ADP-ribose) polymerase. Biochim Biophys Acta 1092, 319-325 (1991)
24. Molnar Z., E. Shearer, D. Lowe: N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: A prospective, randomized, placebocontrolled study. Crit Care Med 27, 1100-1104 (1999) (Pubitemid 29314318)
25. Paterson R. L., H. F. Galley, N. R. Webster: The effect of N-acetylcysteine on nuclear factor-(kappa) B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med 31, 2574-2578 (2003) (Pubitemid 37452835)
26. Cui X., C. Parent, H. Macarthur, S. D. Ochs, E. Gerstenberg, S. Solomon, Y. Fitz, R. L. Danner, S. M. Banks, C. Natanson, D. Salvemini, P. Q. Eichacker: Severity of sepsis alters the effects of superoxide anion inhibition in a rat sepsis model. J Appl Physiol 97, 1349-1357 (2004) (Pubitemid 39299351)
27. Macarthur H., T. C. Westfall, D. P. Riley, T. P. Misko, D. Salvemini: Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. PNAS 97, 9753-9758 (2000) (Pubitemid 30650848)
28. Van der Meer T. J., H. Wang, M. P. Fink: Endotoxemia causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit Care Med 23, 1217-1226 (1995)
29. Fink M. P.: Bench-to-bedside review: Cytopathic hypoxia. Crit Care 6, 491-499 (2002) (Pubitemid 35414580)
30. Suliman H. B., M. S. Carraway, C. A. Piantadosi: Postlipopolysaccharide Oxidative Damage of Mitochondrial DNA. Am J Resp Crit Care Med 167, 570-579 (2002)
31. Crouser E. D., M. W. Julian, D. V. Blaho, D. R. Pfeiffer: Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit Care Med 30, 276-284 (2002) (Pubitemid 34158107)
32. Zapelini P. H., G. T. Rezin, M. R. Cardoso, C. Ritter, F. Klamt, J. C. Moreira, E. L. Streck, F. Dal-Pizzol: Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model. Mitochondrion. 8, 211-218 (2008) (Pubitemid 351837489)
33. Klamt F., F. Dal-Pizzol, D. P. Gelain, R. S. Dalmolin, R. Birnfeld de Oliveira, M. Bastiani, F. Horn, J. C. Fonseca Moreira: Vitamin A treatment induces apoptosis through an oxidant-dependent activation of the mitochondrial pathway. Cell Biol Int 32, 100-106 (2008) (Pubitemid 351249145)
34. Cuzzocrea S., B. Zingarelli, M. O'Connor, A. L. Salzman, C. Szabó: Effect of L-buthionine-(S, R) - sulphoximine, an inhibitor of gamma-glutamylcysteine synthetase on peroxynitrite-and endotoxic shock-induced vascular failure. Br J Pharmacol 123, 525-537 (1998) (Pubitemid 28059722)
35. Szabó C., S. Cuzzocrea, B. Zingarelli, M. O'Connor, A. L. Salzman: Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 100, 723-735 (1997) (Pubitemid 27340522)
36. Anderson M. M., J. R. Requena, J. R. Crowley, S. R. Thorpe, J. W. Heinecke: The myeloperoxidase system of human phagocytes generates N-epsilon-(carboxymethyl) lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest 104, 103-113 (1999) (Pubitemid 29534350)
37. Gao X. P., T. J. Standiford, A. Rahman, M. Newstead, S. M. Holland, M. C. Dinauer, Q. H. Liu, A. B. Malik: Role of NADPH oxidase in the mechanism of lung neutrophil sequestration and microvessel injury induced by Gramnegative sepsis: studies in p47phox-/-and gp91phox-/-mice. J Immunol 168, 3974-3982 (2002) (Pubitemid 34298402)
38. Babior B. M.: NADPH oxidase. Curr Opin Immunol 16, 42-47 (2004) (Pubitemid 38198116)
39. Visner G. A., W. C. Dougall, J. M. Wilson, I. A. Burr, H. S. Nick: Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. J Biol Chem 265, 2856-2864 (1990)
40. Masuda A., D. L. Longo, Y. Kobayashi, E. Appella, J. J. Oppenheim, K. Matsushima: Induction of mitochondrial manganese superoxide dismutase by interleukin 1. FASEB J 2, 3087-3091 (1988) (Pubitemid 19021171)
41. Sappington P. L., R. Yang, H. Yang, K. J. Tracey, R. L. Delude, M. P. Fink: HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 123, 790-802 (2002) (Pubitemid 34977085)
42. Bochkov V. N., A. Kadl, J. Huber, F. Gruber, B. R. Binder, N. Leitinger: Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 419, 77-81 (2002) (Pubitemid 34987873)
43. Yamaji K., Y. Wang, Y. Liu, K. Abeyama, T. Hashiguchi, T. Uchimura, K. Krishna Biswas, H. Iwamoto, I. Maruyama: Activated protein C, a natural anticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation. Thromb Res 115, 319-325 (2005)
44. Taylor Jr F. B., D. J. Stearns-Kurosawa, S. Kurosawa, G. Ferrell, A. C. Chang, Z. Laszik, S. Kosanke, G. Peer, C. T. Esmon: The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 95, 1680-1686 (2000) (Pubitemid 30120829)
45. Yuksel M., K. Okajima, M. Uchiba, S. Horiuchi, H. Okabe: Activated protein C inhibits lipopolysaccharideinduced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. Thromb Haemost 88, 267-273 (2002) (Pubitemid 34873708)
46. Wang H., O. Bloom, M. Zhang, J. M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, K. R. Manogue, E. Faist, E. Abraham, J. Andersson, U. Andersson, P. E. Molina, N. N. Abumrad, A. Sama, K. J. Tracey: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248-251 (1999) (Pubitemid 29329996)
47. Nam NH: Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem 6, 945-951 (2006)
48. Ritter C., A. A. da Cunha, I. C. Echer, M. Andrades, A. Reinke, N. Lucchiari, J. Rocha, E. L. Streck, S. Menna-Barreto, J. C. Moreira, F. Dal-Pizzol: Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat. Crit Care Med 34, 471-477 (2006) (Pubitemid 43145628)
49. Daugherty A., J. L. Dunn, D. L. Rateri, J. W. Heinecke: Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94, 437-444 (1994) (Pubitemid 24218123)
50. Baynes J. W., S. R. Thorpe: Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28, 1708-1716 (2000) (Pubitemid 30628657)
51. Miyazaki A., H. Nakayama, S. Horiuchi: Scavenger receptors that recognize advanced glycation end products. Trends Cardiovasc Med 12, 258-262 (2002) (Pubitemid 35286763)
52. Bierhaus A., T. Illmer, M. Kasper, T. Luther, P. Quehenberger, H. Tritschler, P. Wahl, R. Ziegler, M. Muller, P. P. Nawroth: Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 96, 2262-2271 (1997) (Pubitemid 27425832)
53. Pertynska-Marczewska M., S. Kiriakidis, R. Wait, J. Beech, M. Feldmann, E. M. Paleolog: Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages. Cytokine 28, 35-47 (2004) (Pubitemid 39165619)
54. Min C., E. Kang, S. H. Yu, S. H. Shinn, Y. S. Kim: Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells. Diabetes Res Clin Pract 46, 197-202 (1999)
55. Chen L., Y. Liu, B. Cui, Q. Mi, Y. Huang, L. Fan, Q. Chen, J. Tang, A. Ferro, Y. Ji: 17Beta-oestradiol partially attenuates the inhibition of nitric oxide synthase-3 by advanced glycation end-products in human platelets. Clin Exp Pharmacol Physiol 34, 972-978 (2007) (Pubitemid 47274552)
56. P. J. Grant: Diabetes mellitus as a prothrombotic condition. J Intern Med 262, 157-172 (2007) (Pubitemid 47090159)
57. Schäfer A., J. Bauersachs: Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis. Curr Vasc Pharmacol 6, 52-60 (2008)
58. Wei X. Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, F. Y. Liew: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411 (1995)
59. Lush C. W., G. Cepinskas, W. J. Sibbald, P. R. Kvietys: Endothelial E-and P-selectin expression in iNOS-deficient mice exposed to polymicrobial sepsis. Am J Physiol Gastrointest Liver Physiol 280, G291-297 (2001)
60. Parratt J. R.: Nitric oxide in sepsis and endotoxaemia. J Antimicrob Chemother 41 Suppl A: 31-39 (1998) (Pubitemid 28062142)
61. Liaudet L., A. Rosselet, M. D. Schaller, M. Markert, C. Perret, F. Feihl: Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J Infect Dis 177, 127-132 (1998) (Pubitemid 28030443)
62. McGown C. C., Z. L. Brookes: Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide. Br J Anaesth 98, 163-175 (2007) (Pubitemid 47071995)
63. Yates J. C., R. E. Beamish, N. S. Dhalla: Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy. Am Heart J 102, 210-221 (1981) (Pubitemid 11053151)
64. Singal P. K., K. S. Dhillon, R. E. Beamish, N. Kapur, N. S. Dhalla: Myocardial cell damage and cardiovascular changes due to i.v. infusion of adrenochrome in rats. Br J Exp Pathol 63, 167-176 (1982) (Pubitemid 12125612)
65. Didion S. P., D. A. Kinzenbaw, P. E. Fegan, L. A. Didion, F. M. Faraci: Overexpression of CuZn-SOD prevents lipopolysaccharide-induced endothelial dysfunction. Stroke 35, 1963-1967 (2004) (Pubitemid 38971884)
66. Wang W., S. Jittikanont, S. A. Falk, P. Li, L. Feng, P. E. Gengaro, B. D. Poole, R. P. Bowler, B. J. Day, J. D. Crapo, R. W. Schrier: Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemiarelated acute renal failure. Am J Physiol Renal Physiol 284, F532-537 (2003) (Pubitemid 36227915)
67. Stralin P., S. L. Marklund. Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. Atherosclerosis 151, 433-441 (2000) (Pubitemid 30618760)
68. Szabo C., B. Zingarelli, M. O'Connor, A. L. Salzman: DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci U S A 93, 1753-1758 (1996) (Pubitemid 26079829)
69. Boulos M., M. E. Astiz, R. S. Barua, M. Osman: Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly (ADP-ribose) synthase. Crit Care Med 31, 353-358 (2003) (Pubitemid 36232925)
70. Fourrier F., C. Chopin, J. Goudemand, S. Hendrycx, C. Caron, A. Rime, A. Marey, P. Lestavel: Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 101, 816-823 (1992)
71. Gando S., Y. Nakanishi, I. Tedo: Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med 23, 1835-1842 (1995)
72. Dempfle C. E.: Coagulopathy of sepsis. Throm Haemost 91, 213-224 (2004)
73. Jagneaux T., D. E. Taylor, S. P. Kantrow: Coagulation in Sepsis. Am J Med Sci 328, 196-204 (2004) (Pubitemid 39372461)
74. Herkert O., T. Djordjevic, R. S. Belaiba, A. Görlach: Insights into the Redox Control of Blood Coagulation: Role of Vascular NADPH Oxidase-Derived Reactive Oxygen Species in the Thrombogenic Cycle. Antioxid Redox Signa 6, 765-776 (2004) (Pubitemid 38890794)
75. Görlach A., R. P. Brandes, S. Bassus, N. Kronemann, C. M. Kirchmaier, R. Busse, V. B. Schini-Kerth: Oxidative stress and expression of p22phox are involved in the upregulation of tissue factor in vascular smooth muscle cells in response to activated platelets. FASEB J, 14:1518-1528 (2000) (Pubitemid 30636556)
76. Shacter E., J. A. Williams, M. Lim, R. L. Levine: Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay. Free Radic Biol Med 17, 429-437 (1994) (Pubitemid 24320292)
77. Shacter E., J. A. Williams, R. L. Levine: Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. Free Radic Biol Med 18, 815-821 (1995)
78. Nowak P., H. M. Zbikowska, M. Ponczek, J. Kolodziejczyk, R. Wachowicz: Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: functional consequences. Thromb Res 121, 163-174 (2007) (Pubitemid 350138069)
79. Pieters M., N. Covic, F. H. van der Westhuizen, C. Nagaswami, Y. Baras, D. Toit Loots, J. C. Jerling, D. Elgar, K. S. Edmondson, D. G. van Zyl, P. Rheeder, J. W. Weisel: Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model. Thromb Haemost 99, 691-700 (2008) (Pubitemid 351694225)
80. Grant P. J.: Diabetes mellitus as a prothrombotic condition. J Intern Med 262, 157-172 (2007). (Pubitemid 47090159)
81. Andrades M., C. Ritter, J. C. Moreira, F. Dal-Pizzol: Oxidative parameters differences during non-lethal and lethal sepsis development. J Surg Res 125, 68-72 (2005) (Pubitemid 40523777)
82. Macarthur H., D. M. Couri, G. M. Wilken, T. C. Westfall, A. J. Lechner, G. M. Matuschak, Z. Chen, D. Salvemini: Modulation of serum cytokine levels by a novel superoxide dismutase mimetic, M40401, in an Escherichia coli model of septic shock: correlation with preserved circulating catecholamines. Crit Care Med 31, 237-245 (2003) (Pubitemid 36151178)
83. Zingarelli B., B. J. Day, J. D. Crapo, A. L. Salzman, C. Szabo: The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol 120, 259-267 (1997) (Pubitemid 27039275)
84. Bianca R. V., N. S. Wayman, M. C. McDonald, A. Pinto, M. A. Shape, P. K Chatterjee, C. Thiemermann: Superoxide dismutase mimetic with catalase activity, EUK-134, attenuates the multiple organ injury and dysfunction caused by endotoxin in the rat. Med Sci Monit 8, 1-7 (2002)
85. Gonzalez P. K., J. Zhuang, S. R. Doctrow, B. Malfroy, P. F. Benson, M. J. Menconi, M. P. Fink: EUK-8, a synthetic superoxide dismutase and catalase mimetic, ameliorates acute lung injury in endotoxemic swine. J Pharmacol Exp Ther 275, 798-806 (1995) (Pubitemid 26025549)
86. Aruoma O. I., B. Halliwell, B. M. Hoey, J. Butler: The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6, 593-597 (1989) (Pubitemid 19147809)
87. Sagrista M. L., A. E. Garcia, M. Africa De Madariaga, M. Mora: Antioxidant and pro-oxidant effect of the thiolic compounds N-acetyl-L-cysteine and glutathione against free radical-induced lipid peroxidation. Free Radic Res 36, 329-340 (2002) (Pubitemid 35154078)
88. Ritter C., A. Reinke, M. Andrades, M. R. Martins, J. Rocha, S. Menna-Barreto, J. Quevedo, J. C. Moreira, F. Dal-Pizzol: Protective effect of N-acetylcysteine and deferoxamine on carbon tetrachloride-induced acute hepatic failure in rats. Crit Care Med 32, 2079-2083 (2004)
89. Pinho R. A., P. C. Silveira, L. A. Silva, E. Luiz Streck, F. Dal-Pizzol, J. C. F. Moreira: N-acetylcysteine and deferoxamine reduce pulmonary oxidative stress and inflammation in rats after coal dust exposure. Environ Res 99, 355-360 (2005) (Pubitemid 41676845)
90. Negre-Salvayre A., C. Coatrieux, C. Ingueneau, R. Salvayre: Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol 153, 6-20 (2008)
91. Lutterloh E. C., S. M. Opal, D. D. Pittman, J. C. Jr Keith, X. Y. Tan, B. M. Clancy, H. Palmer, K. Milarski, Y. Sun, J. E. Palardy, N. A. Parejo, N. Kessimian: Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Crit Care 11, R122 (2007)
92. Sell D. R., C. M. Strauch, W. Shen, V. M. Monnier: 2-aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis. Biochem J 404, 269-277 (2007) (Pubitemid 46849598)
93. Bolton W. K., D. C. Cattran, M. E. Williams, S. G. Adler, G. B. Appel, K. Cartwright, P. G. Foiles, B. I. Freedman, P. Raskin, R. E. Ratner, B. S. Spinowitz, F. C. Whittier, J. P. Wuerth: Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol 24, 32-40 (2004) (Pubitemid 38250484)
94. Freedman B. I., J. P. Wuerth, K. Cartwright, R. P. Bain, S. Dippe, K. Hershon, A. D. Mooradian, B. S. Spinowitz: Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). Control Clin Trials 20, 493-510 (1999) (Pubitemid 29460926)
95. Nakamura S., H. Li, A. Adijiang, M. Pischetsrieder, T. Niwa: Pyridoxal phosphate prevents progression of diabetic nephropathy. Nephrol Dial Transplant 22, 2165-2174 (2007) (Pubitemid 47244693)
96. Williams M. E., W. K. Bolton, R. G. Khalifah, T. P. Degenhardt, R. J. Schotzinger, J. B. McGill: Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy. Am J Nephrol 27, 605-614 (2007) (Pubitemid 350014947)
97. Eriksson M., K. Lundkvist, A. Larsson, D. Nelson, T. Saldeen, P. Drott, O. Eriksson: Vitamin A exerts potential therapeutic effects in the endotoxaemic pig. Acta Anaesth Scand 41, 824-829 (1997) (Pubitemid 27317706)
98. Eriksson M., K. Lundkvist, P. Drott, T. Saldeen, O. Eriksson: Beneficial effects of pre-treatment with vitamin A on cardiac and pulmonary functions in endotoxaemic pigs. Acta Anaesth Scand 40, 538-548 (1996) (Pubitemid 26183044)
99. Eriksson M., J. Modig, A. Larsson, O. Rollman, O. Eriksson: Retinyl palmitate injections reduce serum levels and effects of endotoxin on systemic haemodynamics and oxygen transport in the pig. Acta Anaesth Scand 42, 406-413 (1998) (Pubitemid 28138510)
100. Demetriou A. A., I. Franco, S. Bark, G. Rettura, E. Seifter, S. M. Levenson: Effects of vitamin A and beta carotene on intra-abdominal sepsis. Arch Surg 119, 161-165 (1984) (Pubitemid 14181691)
101. Abe S., Y. Tanaka, N. Fujise, T. Nakamura, H. Masunaga, T. Nagasawa, M. Yagi: An Antioxidative Nutrient-Rich Enteral Diet Attenuates Lethal Activity and Oxidative Stress Induced by Lipopolysaccharide in Mice. J Parenter Enteral Nutr 31, 181-187 (2007) (Pubitemid 46676799)
102. Carlson D., D. L. Maass, D. J. White, J. Tan, J. W. Horton: Antioxidant vitamin therapy alters sepsis-related apoptotic myocardial activity and inflammatory responses: Am J Physiol Heart Circ Physiol 29, H2779-89 (2006)
103. Kim J. Y., S. M. Lee: Vitamins C and E protect hepatic cytochrome P450 dysfunction induced by polymicrobial sepsis: Europ J Pharmacol 534, 202-209 (2006)
104. Ochiai J., H. Takano, H. Ichikawa, Y. Naito, N. Yoshida, R. Yanagisawa, S. Yoshino, H. Murase, T. Yoshikawa: A novel water-soluble vitamin E derivative, 2-(alpha-Dglucopyranosyl) methyl-2, 5, 7, 8-tetramethylchroman-6-ol, protects against acute lung injury and mortality in endotoxemic rats: Shock 18, 580-584 (2002)
105. Toklu H. Z., T. Tunali Akbay, A. Velioglu-Ogunc, F. Ercan, N. Gedik, M. Keyer-Uysal, G. Sener: Silymarin, the antioxidant component of Silybum marianum, prevents sepsisinduced acute lung and brain injury. J Surg Res 145, 214-222 (2008) (Pubitemid 351329315)
106. Hsu B. G., R. P. Lee, F. L. Yang, H. J. Harn, H. I. Chen: Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats. Life Science 79, 2010-2016 (2006) (Pubitemid 44528583)